This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

The impact of overlap of drug-eluting stents on clinical and angiographic outcomes is controversial. Individuals with long coronary lesions requiring implantation of multiple stents are an ...

Currently available DES have maximum stent lengths in the low-30-mm range. "As soon as you need to go beyond that, you need to overlap stents, and there are multiple issues associated with ...

An average of 1.4 stents were implanted per target lesion, with overlapping stents in 28 percent of patients. Quantitative Coronary Angiography The dimensions of the lesion at base line were ...

The impact of using a single stent to cover all of the lesion or the use of multiple overlapping stents was also associated with a better outcome in SES-treated patients ( Table 3).

Moreover, overlapping stents were implanted in relatively few patients in this trial, and thus, further study is required to evaluate the treatment of lesions that are longer than 28 mm, ...

A novel 48-mm stent for the treatment of diffuse de novo coronary artery lesions was found to be safe and effective at 1 year, with a high level of device deliverability, a speaker reported.The ...

Introduction. Since their introduction, drug-eluting stents (DES) have revolutionized percutaneous treatment of coronary artery disease with rates of in-stent restenosis of between 2 and 10% [] and ...

The Xience Skypoint 48 stent had a target lesion failure (TLF) rate of 5.7% at 1 year, with a 95% CI upper bound of 9.5% that fell within the performance goal of 20%, reported researchers led by ...

PHOENIX, AZ—In patients with diffuse CAD, a next-generation, longer-length stent may eliminate the need for multiple overlapping devices for treating long, continuous plaques, according to results ...